TB Research

<i>Mycobacterium tuberculosis</i> Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival

Dallas A. Banks, Sarah E. Ahlbrand, V. Keith Hughitt, Swati Shah, Katrin D. Mayer-Barber, Stefanie N. Vogel, Najib M. El-Sayed, Volker Briken

The Journal of Immunology · 2019-03

Abstract

Abstract The type I IFNs (IFN-α and -β) are important for host defense against viral infections. In contrast, their role in defense against nonviral pathogens is more ambiguous. In this article, we report that IFN-β signaling in murine bone marrow–derived macrophages has a cell-intrinsic protective capacity against Mycobacterium tuberculosis via the increased production of NO. The antimycobacterial effects of type I IFNs were mediated by direct signaling through the IFN-α/β–receptor (IFNAR), as Ab-mediated blocking of IFNAR1 prevented the production of NO. Furthermore, M. tuberculosis is able to inhibit IFNAR-mediated cell signaling and the subsequent transcription of 309 IFN-β–stimulated genes in a dose-dependent way. The molecular mechanism of inhibition by M. tuberculosis involves reduced phosphorylation of the IFNAR-associated protein kinases JAK1 and TYK2, leading to reduced phosphorylation of the downstream targets STAT1 and STAT2. Transwell experiments demonstrated that the M. tuberculosis–mediated inhibition of type I IFN signaling was restricted to infected cells. Overall, our study supports the novel concept that M. tuberculosis evolved to inhibit autocrine type I IFN signaling to evade host defense mechanisms.

MeSH terms

  • Autocrine signalling
  • STAT2
  • STAT1
  • Mycobacterium tuberculosis
  • Signal transduction
  • Biology
  • Phosphorylation
  • Interferon
  • Cell biology
  • Tuberculosis
  • Tyrosine kinase 2
  • Kinase
  • Cell signaling
  • Cancer research
  • Receptor
  • Immunology
  • Microbiology